Publications

4527 Results

Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci

Authors
L Sucheston-Campbell;A Clay;W Barlow;GT Budd;D Stram;C Haiman;X Sheng;L Yan;G Zirpoli;S Yao;C Jiang;K Owzar;D Hershman;KS Albain;D Hayes;H Moore;J Hobday;JA Stewart;C Isaacs;M Salim;J Gralow;G Hortobagyi;R Livingston;D Kroetz;C Ambrosone
Journal / Conference
Pharmacogenetics and Genomics Feb;28(2):49-55
Year
2018
Research Committee(s)
Breast
PMID
PMID29278617
Study Number(s)
S0221

Tandem autologous hematopoietic cell transplantation for patients with primary progressive or recurrent hodgkin lymphoma: a SWOG and Blood & Marrow Transplant Clinical Trials Network phase II Trial (SWOG S0410/BMT CTN 0703)

Authors
EP Smith;H Li;J Friedberg;L Constine;L Rimsza;G Laport;L Popplewell;L Holmberg;SM Smith;SM Smith;M Leblanc;SJ Forman;RI Fisher;PJ Stiff
Journal / Conference
Biology of Blood and Marrow Transplantation Apr;24(4):700-707
Year
2018
Research Committee(s)
Lymphoma
PMID
PMID29289757
PMC
PMC5965270
Study Number(s)
S0410

An intergroup randomized phase II study of bevacizumab or cetuximab in combination with gemcitabine and in combination with chemoradiation (capecitabine and radiation) in patients with resected pancreatic carcinoma: a trial of the ECOG-ACRIN Cancer Research Group (E2204)

Authors
JD Berlin;Y Feng;P Feng;P Catalano;J Abbruzzese;P Philip;RR Mcwilliams;A Lowy;A Benson;W Blackstock
Journal / Conference
Oncology 94(1):39-46
Year
2018
Research Committee(s)
Gastrointestinal
PMID
PMID29040974
PMC
PMC5828967
Study Number(s)
CTSU/E2204

SWOG S0713: A phase II study of cetuximab added to induction chemotherapy of oxaliplatin and capecitabine, followed by neoadjuvant chemoradiation for locally advanced rectal cancer

Authors
C Leichman;S McDonough;S Smalley;K Billingsley;H Lenz;M Beldner;A Hezel;M Velasco;K Guthrie;C Blanke;H Hochster
Journal / Conference
Clinical Colorectal Cancer Mar;17(1):e121-e125; 2017 Oct 24 [Epub ahead of print]
Year
2018
Research Committee(s)
Gastrointestinal
PMID
PMID29233486
Study Number(s)
S0713

The scientific impact and value of large, NCI-sponsored randomized phase III cancer prevention trials

Authors
JM Unger;W Barlow;CM Tangen;SD Ramsey;IM Thompson;EA Klein;M LeBlanc;CD Blanke;P Goodman;LM Minasian;DL Hershman
Journal / Conference
Cancer Epidemiology Jun 21;55:117-122
Year
2018
Research Committee(s)
Cancer Control and Prevention
PMID
PMID29936140
PMC
PMC Journal - In Process
Study Number(s)
S0000, SWOG-9217

Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia

Authors
RB Walter;LC Michaelis;M Othus;GL Uy;JP Radich;RF Little;RF Little;S Hita;L Saini;JM Foran;AT Gerds;HD Klepin;AE Hay;JE Lancet;S Couban;MR Litzow;RM Stone;HP Erba
Journal / Conference
American Journal of Hematology Feb;93(2):E49-E52
Year
2018
Research Committee(s)
Leukemia
PMID
PMID29164656
PMC
PMC5760282
Study Number(s)
S1612

Survival by Hispanic Ethnicity among Cancer Patients Participating in SWOG Clinical Trials

Authors
M Chavez-MacGregor;J Unger;A Moseley;S Ramsey;DL Hershman
Journal / Conference
Cancer Apr 15;124(8):1760-1769; Jan 25 [Epub ahead of print]
Year
2018
Research Committee(s)
Breast, Gastrointestinal, Genitourinary, Leukemia, Lung, Lymphoma, Myeloma, and Sarcoma
PMID
PMID29370458
PMC
PMC5963502
Study Number(s)
S0003, S0012, S0016, S0033, S0106, S0221, S0226, S0232, S0307, S0421, S0500, SWOG-8516 (INT-0067), SWOG-8600, SWOG-8809, SWOG-8814, SWOG-8894 (INT-0105) (EST-2889), SWOG-8897, SWOG-8905, SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195), SWOG-9031, SWOG-9125, SWOG-9210, SWOG-9240, SWOG-9304 (INT-0144), SWOG-9308, SWOG-9313, SWOG-9321, SWOG-9333, SWOG-9346, SWOG-9349, SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415), SWOG-9420, SWOG-9509, S9623, S9704, S9800, S9911, S9916

Randomized Multicenter Placebo-Controlled Clinical Trial of Duloxetine versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early Stage Breast Cancer: SWOG S1202

Authors
NL Henry;JM Unger;AF Schott;L Fehrenbacher;PJ Flynn;DM Prow;CW Sharer;GV Burton;CS Kuzma;A Moseley;DL Lew;MJ Fisch;CM Moinpour;DL Hershman;JL Wade
Journal / Conference
Journal of Clinical Oncology Feb 1;36(4):326-332
Year
2018
Research Committee(s)
Symptom Control and Quality of Life
PMID
PMID29136387
PMC
PMC5805479
Study Number(s)
S1202

A randomized, phase III study of carboplatin/paclitaxel or carboplatin/paclitaxel/ bevacizumab with or without concurrent cetuximab investigating EGFR FISH in patients with advanced non-small cell lung cancer: SWOG S0819

Authors
R Herbst;M Redman;ES Kim;E Semrad;L Bazhenova;G Masters;K Oettel;P Guaglianone;C Reynolds;A Karnad;S Arnold;M Varella-Garcia;J Moon;PC Mack;C Blanke;F Hirsch;K Kelly;D Gandara
Journal / Conference
Lancet Oncology Jan;19(1):101-114. Epub 2017 Nov 20.Nov 20. [Epub ahead of print]
Year
2018
Research Committee(s)
Lung
PMID
PMID9169877
PMC
PMC5847342
Study Number(s)
S0819

Impact of specimen heterogeneity on biomarkers in repository samples from patients with AML: a SWOG report

Authors
E Pogosova-Agadjanyan;A Moseley;M Othus;F Appelbaum;T Chauncey;I-M Chen;HP Erba;J Godwin;M Fang;K Kopecky;AF List;G Pogosov;J Radich;C Willman;BL Wood;S Meshinchi;D Stirewalt
Journal / Conference
Biopreservation and Biobanking Feb;16(1):42-52; Nov 27 [Epub ahead of print]
Year
2018
Research Committee(s)
Leukemia
PMID
PMID29172682
PMC
PMC5808392
Study Number(s)
S0106, S0112, SWOG-9031, SWOG-9333